Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Depreciation and Depletion: 2023-2024

Historic Depreciation and Depletion for Seres Therapeutics (MCRB) over the last 1 years, with Sep 2024 value amounting to $333,000.

  • Seres Therapeutics' Depreciation and Depletion was N/A to $333,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $989,000 for FY2024, which is 51.02% down from last year.
  • Per Seres Therapeutics' latest filing, its Depreciation and Depletion stood at $333,000 for Q3 2024, which was up 1.52% from $328,000 recorded in Q2 2024.
  • Seres Therapeutics' Depreciation and Depletion's 5-year high stood at $551,000 during Q4 2023, with a 5-year trough of $328,000 in Q1 2024.
  • In the last 2 years, Seres Therapeutics' Depreciation and Depletion had a median value of $330,500 in 2024 and averaged $385,000.